Atlas Trials

A Study of Multiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque Psoriasis

Clinical trial NCT02223039 · COMPLETED

Trial details

NCT number
NCT02223039
Sponsor
AbGenomics B.V Taiwan Branch
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Moderate to Severe Chronic Plaque Psoriasis
Start date
2014-05-01
Primary completion
2014-12-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.